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Abstract Children with chronic kidney disease (CKD) have
multiple risk factors for impaired accretion of trabecular and
cortical bone. CKD during childhood poses an immediate
fracture risk and compromises adult bone mass, resulting in
significantly greater skeletal fragility throughout life. High-
turnover disease initially results in thickened trabeculae, with
greater bone volume. As disease progresses, resorption
cavities dissect trabeculae, connectivity degrades, and bone
volume decreases. Increased bone turnover also results in
increased cortical porosity and decreased cortical thickness.
Dual-energy X-ray absorptiometry (DXA)-based measures of
bone mineral density (BMD) are derived from the total bone
mass within the projected bone area (g/cm2), concealing
distinct disease effects in trabecular and cortical bone. In
contrast, peripheral quantitative computed tomography
(pQCT) estimates volumetric BMD (vBMD, g/cm3), distin-
guishes between cortical and trabecular bone, and provides
accurate estimates of cortical dimensions. Recent data have
confirmed that pQCT measures of cortical vBMD and
thickness provide substantially greater fracture discrimina-
tion in adult dialysis patients compared with hip or spine
DXA. The following review considers the structural effects
of renal osteodystrophy as it relates to fracture risk and the
potential advantages and disadvantages of DXA and alter-
native measures of bone density, geometry, and micro-
architecture, such as pQCT, micro-CT (μCT), and micro
magnetic resonance imaging (μMRI) for fracture risk
assessment.
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Introduction
Renal osteodystrophy is a multifactorial and universal
disorder of bone metabolism in chronic kidney disease
(CKD). As renal failure progresses, ensuing abnormal
parathyroid hormone (PTH) secretion results in deterioration
of trabecular microarchitecture, thinning of cortical bone,
and increased cortical porosity [1]. Despite widespread use
of phosphate binders and vitamin D therapies, hip fracture
rates in young adults on dialysis are 100-fold greater than in
healthy controls [2]. Successful renal transplantation cor-
rects many of the underlying abnormalities contributing to
renal osteodystrophy. However, persistent hyperparathy-
roidism, immunosuppressive therapies, and renal allograft
dysfunction may impair recovery of renal osteodystrophy
and lead to further bone loss. Hip fracture rates among adult
dialysis patients undergoing renal transplantation increase
even further in the early months following transplantation,
then gradually decline [3]. Significantly greater vertebral
and extremity fracture rates have also been demonstrated in
pediatric solid organ transplant recipients compared with
healthy controls: the age- and sex- adjusted hazard ratios
for vertebral fractures were 61.3 [95% confidence interval
(CI), 40.7–92.4) compared with over 200,000 population-
based controls [4].
Throughout childhood and adolescence, normal bone
mineral acquisition results in gender-, maturation-, and site-
specific increases in bone density and dimensions. Children
with CKD have multiple risk factors for impaired bone
development, including abnormal mineral metabolism,
secondary hyperparathyroidism, poor linear growth, delayed
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development, malnutrition (including vitamin D insufficien-
cy), decreased weight-bearing activity, and immunosuppres-
sive therapies. The impact of these threats to bone health
may be immediate, resulting in fragility fractures, or delayed,
due to suboptimal peak bone mass accrual. The signs and
symptoms of renal bone disease seen in adults, such as
subperiosteal resorption, osteosclerosis, fractures and muscle
weakness, may also complicate CKD in childhood. In
addition, the effects of abnormal bone and mineral metab-
olism on endochondral ossification during growth result in
complications in the epiphyseal region that are unique to
children with CKD. These complications include linear
growth failure, slipped epiphyses, and skeletal deformities
resembling vitamin-D-deficient rickets. Back pain, scoliosis,
and narrowed, degenerated disc spaces also complicate renal
transplantation in childhood [5].
The majority of studies of bone loss in CKD relied on
dual-energy X-ray absorptiometry (DXA) measures of bone
mineral density (BMD). However, DXA summarizes the
total bone mass within the projected bone area (g/cm2),
concealing distinct structural alterations in trabecular and
cortical bone density and architecture. DXA has additional
important limitations in children and adolescents, such as
sparse reference data and lack of consensus regarding
techniques to adjust for the confounding effect of bone size,
as described by us [6] and others [7] in this journal. The
following review considers the structural effects of renal
osteodystrophy as it relates to fracture risk and the potential
advantages and disadvantages of DXA and alternative
measures of bone density, geometry, and microarchitecture,
such as peripheral quantitative computed tomography
(pQCT), micro-CT (μCT), and micro magnetic resonance
imaging (μMRI) for fracture risk assessment.
Histomorphometry of renal osteodystrophy
Renal osteodystrophy is an early, pervasive. and multifactorial
disorder of bone remodeling that often develops prior to any
clinical manifestations of CKD [1]. The classic form of renal
osteodystrophy is high-turnover disease due to secondary
hyperparathyroidism. Phosphate retention, hypocalcemia,
reduced renal 1α-hydroxylation of 25(OH) vitamin D to
generate 1,25(OH)2 vitamin D, and skeletal resistance to the
actions of PTH contribute to the marked hyperparathyroid-
ism in CKD. Therapies to increase serum calcium, decrease
serum phosphate, and reduce PTH levels have resulted in
decreased frequency and severity of hyperparathyroidism.
However, the incidence of low-turnover disease (adynamic
bone disease) has subsequently increased.
Whereas early case series of bone biopsy results in
children on maintenance dialysis reported high-turnover
bone disease (osteitis fibrosa and mild lesions of secondary
hyperparathyroidism) in the vast majority of patients [8–
10], more recent series identified adynamic bone in a
substantial proportion (27–33%) of children and adoles-
cents [11–13]. The implications of low bone turnover for
bone structure and strength during growth are not known;
however, this bone lesion is associated with increased
fracture risk in adults [14] — perhaps due to impaired
microfracture repair. It has been suggested that intermittent
calcitriol therapy combined with calcium-containing phos-
phate binders may adversely affect chondrocyte activity in
the epiphyseal growth plate, with a consequent reduction in
linear growth. Studies on the relations between adynamic
bone, suppression of PTH with vitamin D therapies, and
growth in children have yielded conflicting results [15–17].
The trabecular manifestations of renal osteodystrophy
are well-described in iliac crest bone biopsies [18]. The
increased remodeling rate in high-turnover disease initially
results in thickened, irregularly shaped trabeculae with
increased bone volume [19]. Increased bone volume is not
necessarily equated with greater bone strength because the
irregular trabeculae may lose their proper three-dimensional
(3D) architecture and connectivity. As disease progresses,
resorption cavities dissect trabeculae, connectivity degrades,
and bone volume decreases. Low-turnover disease is
associated with decreased bone volume and variable alter-
ations in trabecular architecture.
Traditionally, reports of bone biopsies in patients with renal
osteodystrophy focused on trabecular morphology to the
exclusion of cortical bone. However, hyperparathyroidism
may increase subperiosteal, endosteal, and intracortical
resorption, resulting in cortical bone loss on multiple surfaces
[1]. The catabolic effect of increased PTH on cortical bone
structure is primarily characterized by increased cortical
porosity and decreased cortical thickness. A study of full-
thickness bone biopsies in adult dialysis patients demon-
strated a 45% reduction in cortical bone volume in both
high-turnover and low-turnover disease [19].
Although I am unaware of any reports of cortical bone
porosity or dimensions on bone biopsies in children with CKD,
pQCT studies of cortical bone in children and adolescents
confirm significant deficits in density and dimensions. Lima et
al. reported that cortical volumetric bone mineral density
(vBMD, g/cm3) was significantly lower in children with
CKD compared with controls [20]. Ruth et al. reported that
cortical thickness was significantly lower in the proximal and
distal radius and the metacarpal shaft in pediatric renal
transplant recipients compared with controls [21].
Skeletal structure, strength, and fracture risk
The clinical significance of impaired bone structure lies in
the occurrence of fractures. Bone strength reflects the
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integration of two main features: bone density and bone
quality [22]. Bone quality refers to bone architecture,
turnover, damage accumulation (e.g. microfractures) and
mineralization. CKD likely has adverse effects on each of
these components of bone quality. Cortical bone comprises
more than 80% of skeletal mass and fulfills a predominant-
ly mechanical function. Cortical bone strength depends on
bone geometry, bone density, and the location and direction
of applied loads [23]. The long bones are tubular structures
that are loaded mainly in bending. The resistance of long bones
to bending (i.e. bone strength) is represented by the cross-
sectional moment of inertia CSMIð Þ ¼ π=4 R4p

R4eÞ; Rp
and Re indicate the periosteal and endosteal radius [24].
These power relationships indicate that small decreases in
cortical Rp or increases in Re markedly decrease bone-
bending strength. In addition, cortical vBMD also contrib-
utes to bone strength. Ferretti et al. demonstrated that the
bone strength index (a measure of CSMI weighted for
cortical vBMD) explained 94% of the variability in fracture
load in rat femurs [25].
The strength of trabecular bone and its resistance to fracture
traditionally have been associated with bone quantity, e.g.
bone volume/total volume [BV/TV; or bone volume fraction
(BVF)] or apparent density (g/cm2 or g/cm3). However,
trabecular microarchitectural parameters, such as trabecular
thickness, number, spacing, orientation (i.e. anisotropy),
connectivity, and the ratio of plate- and rod-like structures
all contribute to bone strength [26]. For example, a 3D
analysis of the spine in autopsy cases in dialysis patients
demonstrated normal to increased trabecular BV/TV but
abnormal connectivity with frequent and severe trabecular
perforations and microcallus formation [27]. Spinal deformi-
ties were observed despite normal BV/TV and were
attributed to the abnormal trabecular microarchitecture.
Skeletal modeling during growth and development
The shape and structure of bones is continuouslymodified and
renovated by the two processes of modeling and remodeling.
Both result in the replacement of old bone with new bone.
Remodeling is the major process in adults and does not result
in a change of the bone shape. Remodeling takes place in the
basic bone multicellular units on the trabecular surface and
within the cortical bone. Normally, bone resorption by
osteoclasts is followed by bone formation by osteoblasts;
teams of osteoclasts and osteoblasts are juxtaposed in the bone
multicellular unit, and bone resorption and formation are
tightly coupled. Skeletal remodeling is vital to microdamage
repair. However, after midadulthood, the amount of resorption
exceeds formation, resulting in a negative bone balance.
In contrast, modeling results in new bone formed at a
location different from the site of bone resorption;
formation and resorption are not coupled within a bone
multicellular unit. Modeling results in an increase in bone
diameter and modification of bone shape with linear
growth. Growth in the diameter of the cortical shaft is the
result of bone formation at the outer (periosteal) surface and
bone resorption at the inner (endosteal) surface. Simulta-
neously, the growth plate moves upward and the wider
metaphysis is reshaped into a diaphysis by continuous
resorption by osteoclasts beneath the periosteum. The
impact of CKD on bone modeling in children has not been
characterized.
Cortical and trabecular bone do not respond in the same
way to diseases, drugs, growth factors, or sex hormones
and should be considered as distinct functional entities.
Trabecular vBMD, as measured by spine QCT, does not
increase before puberty [28, 29]. During puberty, trabecular
vBMD increases significantly due to increases in trabecular
thickness. The increases in vBMD are comparable in girls
and boys [30] but are significantly greater in black
adolescents than in white adolescents [31].
Sex differences in cortical dimensions are established
during puberty: cortical width increases by periosteal bone
formation in boys and by less periosteal bone formation but
more endocortical apposition in girls [32]. Androgens
stimulate periosteal apposition whereas estrogens inhibit
periosteal apposition and stimulate endosteal apposition.
Therefore, boys have a greater cortical CSMI and stronger
bones. The timing of CKD relative to pubertal maturation
likely has important implications for life-long alterations in
bone structure and strength.
Quantitative assessment of bone status in children
and adolescents
DXA is widely accepted as a quantitative measurement
technique for assessing skeletal status. In elderly adults,
DXA BMD is a sufficiently robust predictor of osteoporotic
fractures that it can be used to define the disease. The
diagnosis of osteoporosis in adults is based on a T score, the
comparison of a measured BMD result with the average
BMD of young adults at the time of peak bone mass [33].
Clearly, it is inappropriate to compare a child’s BMD with
that of a young adult. Rather, children are assessed relative
to age or body size, expressed as a Z score. Despite the
growing body of published normative data utilizing DXA
in children, there are no evidence-based guidelines for the
definition of osteoporosis in children. Fractures occur
commonly in otherwise healthy children, with a peak
incidence during early adolescence around the time of the
pubertal growth spurt [34]. Several studies have compared
the DXA BMD of normal children and adolescents with
forearm fractures to that of age-matched controls without
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fractures. Most [35–39], but not all [40, 41], found that
mean DXA BMD was significantly lower in children with
forearm fractures than in controls.
A significant limitation of DXA is the reliance on
measurement of areal rather than volumetric BMD. DXA
provides an estimate of BMD expressed as grams per
anatomical region (e.g. individual vertebrae, whole body, or
hip). Dividing the BMC within the defined anatomical
region (g) by the projected area of the bone (cm2) then
derives “areal BMD” (g/cm2). This BMD is not a measure
of vBMD (g/cm3) because it provides no information about
the depth of bone. Bones of larger width and height also
tend to be thicker. As bone thickness is not factored into
DXA estimates of areal BMD, reliance on DXA inherently
underestimates the bone density of short people. Despite
identical vBMD, the child with smaller bones appears to
have a mineralization disorder (decreased areal BMD) [42].
This is clearly an important artifact in children with chronic
diseases, such as CKD, that are associated with poor
growth. For this reason, many investigators advocate that
areal BMD should not be used in growing children [43–45].
Limitations of DXA in CKD
DXA has additional important limitations in patients with
CKD; these limitations were recently reviewed in children
undergoing renal transplantation [6]. A study in adults with
primary hyperparathyroidism illustrates the limitations of
DXA in the setting of increased PTH [46]. Trabecular and
cortical bone behave differently in response to increased
PTH activity: trabecular bone mass increases and cortical
bone mass decreases [1]. The two-dimensional (2D)
posterior–anterior DXA projection of the spine captures
the largely trabecular vertebral body as well as the super-
imposed cortical spinous processes. However, the lateral
projection allows one to distinguish between the vertebral
body and posterior elements. As shown in Fig. 1, mean
spine BMD on the posterior–anterior projection was
normal; however, the lateral scan revealed increased BMD
in the predominantly trabecular vertebral body and de-
creased BMD in the cortical spinous processes. Consistent
with the cortical bone loss in patients with primary
hyperparathyroidism, the International Society of Clinical
Densitometry (http://www.iscd.org/Visitors/positions) rec-
ommends that DXA scans should be performed in the distal
one third of the radius (an entirely cortical site) in patients
with hyperparathyroidism rather than in the predominantly
trabecular lumbar spine or femoral neck.
DXA has been used extensively to evaluate patients with
renal osteodystrophy. Clearly, because trabecular and
cortical bone behave differently in response to increased
parathyroid activity and DXA does not distinguish between
renal osteodystrophy effects on the two types of bone, DXA
is of limited value in CKD. The conflicting data on DXA-
derived measures of BMD in CKD are consistent with these
limitations: DXA results in adults have been variable, with
mean BMD values higher than, the same as, or lower than
control subjects (reviewed in reference [1]). The interpre-
tation of DXA results in children with CKD are further
complicated by the confounding effects of poor growth.
These difficulties are well-illustrated in the study by Saland
et al. [48] in which DXA lumbar spine scans were obtained
in 33 children with functional renal allografts an average of
4 years after transplantation. These children had marked
growth failure; the mean height Z score was −2.0+1.2. The
Posterior-Anterior Lateral
Mean BMD z-score:     -0.05   - 0.65 + 0.64
Fig. 1 Differential effects of pri-
mary hyperparathyroidism on
posterior–anterior and lateral dual-
energy X-ray absorptiometry
(DXA) bone mineral density
(BMD) in the spine in adults (data
derived from Duan et al. [47]
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mean DXA BMD Z score relative to gender and chrono-
logic age was −0.9+1.3. However, when the BMD Z score
was generated relative to gender and height age, the BMD
Z score was significantly greater (p<0.001), at 0.4+1.4.
The difference between the age-specific and height age-
specific BMD Z scores were most pronounced in the
pubertal transplant recipients. The comparison with controls
of the same height age eliminated the confounding effect of
bone size; however, this is an incomplete solution, as the
renal patients were significantly older than the controls of
comparable height. Therefore, the greater BMD in renal
patients may represent the effects of greater maturity. Given
the extreme short stature of many renal patients, it is not
possible to simultaneously adjust for bone size and pubertal
maturation.
Early studies of DXA BMD and fracture discrimination
yielded conflicting results. Atsumi et al. assessed 187
hemodialysis patients and reported that each standard
deviation (SD) decrease in lumbar spine BMD increased
the age-adjusted odds ratio (OR) of vertebral fracture 2.0-
fold (95% CI: 1.4–2.0) [49]. However, subsequent studies
reported that DXA spine BMD provided poor fracture
discrimination in dialysis patients and transplant recipients
[50–52]. For example, a cross-sectional study of 104
dialysis patients demonstrated comparable spine BMD in
the 54 patients with vertebral fractures or fragility fractures
compared with those without fractures [51]. Furthermore,
the sensitivity and specificity of a DXA spine BMD T score
of less than −2.5 (World Health Organization definition of
osteoporosis) for the detection of vertebral or fragility
fractures were only 25% and 78%, respectively. That is,
among subjects with a fracture, 25% had a T score less than
−2.5 (sensitivity 25%), and among those without a fracture,
22% had a T score less than −2.5 (specificity 78%).
Therefore, the likelihood of a T score less than −2.5 was
comparable in patients with and without fracture. The fact
that DXA discriminates poorly between fracture and non-
fracture cases is not surprising, given that DXA captures
poorly the effects of CKD on cortical and trabecular density
and quality. I am not aware of any studies relating BMD to
fracture risk in children with CKD.
QCT
CT provides a cross-sectional image unobscured by
overlying structures [53]. The CT attenuation of different
tissues provides quantitative information, referred to as
quantitative CT (QCT). In contrast to DXA, this technique
describes authentic vBMD (g/cm3), accurately measures
bone dimensions, and distinguishes between cortical and
trabecular bone. In order to minimize radiation exposure,
special high-resolution scanners were developed for the
peripheral skeleton (pQCT). PQCT can be used to assess
trabecular vBMD in the ultradistal radius or tibia and cortical
vBMD, periosteal dimensions, and endosteal dimensions in
the midshaft. Figure 2 illustrates the endosteal bone loss
observed in a 9-year renal transplant recipient at the time of
transplantation at our institution, compared with an age,
sex, and height-matched control.
Radius pQCT data illustrate the distinct effects of renal
osteodystrophy, amenorrhea, and glucocorticoids on cortical
and trabecular vBMD (Table 1) [54]. Renal osteodystrophy
resulted in increased trabecular vBMD and markedly
decreased cortical vBMD, whereas amenorrhea or glucocor-
ticoid therapy resulted in the expected reductions in trabecular
vBMD. Spine QCT data in CKD confirmed biopsy histo-
morphometric data: trabecular vBMD was increased in high-
turnover disease (+1.6 SD) and decreased in low-turnover
disease (−1.2 SD) relative to age-matched controls [55]. A
recent pQCT study in 12 adult transplant recipients demon-
strated a significantly greater endosteal circumference and
lower cortical thickness compared with controls [56]. Total
 600 mg/cm3  
 400 mg/cm3  
 200 mg/cm3  




Fig. 2 Peripheral skeleton quantitative computed tomography (pQCT)
scans in the midshaft of the tibia in a pediatric renal transplant recipient
(a) and healthy control (b). This figure illustrates the bone loss on the
endosteal surface and the reduced endocortical volumetric bone mineral
density (vBMD)
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time on dialysis prior to renal transplantation correlated
negatively with cortical thickness (r=0.62; p<0.01).
A pQCT study in children illustrated the opposing effects
of renal osteodystrophy on cortical and trabecular vBMD
[20]. PQCT scans and bone biopsies were obtained in 21
children and adolescents treated with maintenance perito-
neal dialysis. Trabecular vBMD was significantly greater in
CKD subjects compared with controls (p<0.0001), whereas
cortical vBMD was significantly lower in CKD subjects
compared with controls (p<0.001). Trabecular vBMD was
lower in patients with adynamic bone compared with those
with high-turnover lesions (p<0.001). In contrast, cortical
vBMD was higher in patients with adynamic bone
compared with those with high-turnover lesions (p<0.05).
Data on cortical thickness or CSMI were not provided.
Although pQCT discriminates between trabecular and
cortical bone and provides details regarding cortical density
and geometry, pQCT is not of sufficient resolution to
provide detailed microarchitectural information in the
trabecular sites. This limitation is illustrated in the study
below relating pQCT measures to fracture risk.
DXA and pQCT receiver operating characteristic curves
in CKD
The diagnostic test characteristics of the varied imaging
modalities in discriminating fracture risk is best assessed
using receiver-operating characteristic (ROC) curves [57,
58]. To assess the discriminative ability of the varied tests,
ROC curves can be constructed for each scan outcome; e.g.
DXA areal-BMD, pQCT cortical thickness, or pQCT
trabecular vBMD. ROC curves plot the sensitivity on the
y-axis versus 1-specificity on the x-axis. A variable that has
excellent predictive power for fracture will tend, at all
possible cutoff values, to have greater sensitivity (and
hence be farther “up”) and greater specificity (and hence be
farther to the left), than a test with worse predictive value.
The predictive power is assessed by computing the area
under the ROC curve, or the AUC; as the AUC approaches
1.0, the greater the predictive power of the test. To compare
measures directly (e.g. to test the hypothesis that pQCT
measures of cortical vBMD provide better fracture discrim-
ination than DXA areal BMD), one can test the equality of
the AUC values using a χ2 test.
A recent cross-sectional ROC study in 52 adults on
maintenance hemodialysis demonstrated that reductions in
pQCT measures of cortical bone in the radius were strongly
predictive of vertebral and fragility fractures, whereas
pQCT trabecular vBMD and DXA areal BMD were not
[59]. Table 2 illustrates the marked differences in the odds
of fracture and AUC at each site. For example, the AUC for
DXA areal BMD in the hip was only 0.56, whereas the
AUC for pQCT cortical vBMD was 0.89; this difference
was significant, as illustrated in Fig. 3. The clinical
significance of these marked differences is highlighted by
the OR in Table 2. Of note, this study did not include DXA
measures in the radius. Therefore, it is not known if DXA
measures in the cortical midshaft of the radius will improve
fracture discrimination. Finally, the failure of pQCT
trabecular vBMD to discriminate fractures in dialysis
patients is not surprising, given that pQCT does not have
sufficient resolution to detect the unique effects of renal
osteodystrophy on trabecular microarchitecture independent
of bone quantity. Recall that a 3D analysis of the spine in
autopsy cases in dialysis patients demonstrated that abnor-
mal connectivity was associated with vertebral deformities
despite normal to increased BV/TV [27].
Research applications: micro-CT and micro-MRI
The newest generation of high-resolution CT and MRI
scanners can be used to evaluate bone microarchitecture.
For example, we recently used μCT to assess the structure
effects of severe high-turnover renal osteodystrophy on
Table 1 Peripheral quantitative computed tomography (pQCT)
measures of metabolic bone disease in the radius [54]
Dialysis Amenorrhea Glucocorticoid
therapy
Number 10 17 37
Age (years) 39.7±3.7 26.9±6.4 34.1±7.4
Trabecular
vBMD
+0.50 SD −1.49 SD −0.39 SD
Cortical vBMD −2.19 SD −0.76 SD −0.06 SD
vBMD volumetric bone mineral density
Table 2 Association between fractures and peripheral skeleton
quantitative computed tomography (pQCT) or dual-energy X-ray
absorptiometry (DXA) measures in adult hemodialysis patients [59]






Trabecular vBMD 1.18 (0.60, 2.33) 0.52 (0.34, 0.39)
Cortical vBMD 16.67 (2.94, 83.3) 0.89 (0.90, 0.99)
Cortical Thickness 3.26 (1.36, 7.87) 0.78 (0.63, 0.93)
DXA
Spine areal BMD 0.53 (0.27, 1.06) 0.63 (0.48, 0.78)
Femoral neck areal BMD 0.69 (0.36, 1.30) 0.42 (0.23, 0.57)
Total hip areal BMD 1.10 (0.85, 2.08) 0.56 (0.30, 0.63)
vBMD volumetric bone mineral density, BMD bone mineral density
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trabecular and cortical architecture in growing rats [60].
Figure 4 illustrates the irregular trabecular thickening and
loss of trabecular connectivity in rats with severe secondary
hyperparathyroidism. Cortical scans revealed significantly
greater endocortical porosity in the rats with renal osteodys-
trophy compared with controls. Note that these scans were
obtained at 8-μm resolution (Fig. 4) and scan acquisition
required greater than 3 h; therefore, this technique is limited
to in vitro applications.
Micro-MRI can be performed in vivo and has been used
to illustrate that age-related and postmenopausal bone loss
proceeds via inhomogeneous thinning of trabecular plates,
leading to fenestration of plates and conversion to rods.
These rods may become disconnected and eventually
resorbed entirely. Recent advances in μMRI, in conjunction
with image processing and feature extraction processes,
allow detailed structural information to be obtained from
the μMRI “virtual bone biopsy” [61]. In addition to
morphologic parameters synonymous to standard histo-
morphometry [e.g. BV/TV, trabecular separation (Tb.Sp),
trabecular thickness (Tb.Th) and trabecular number (Tb.N)],
digital topologic analysis of μMRIs generates estimates of
trabecular connectivity and the conversion of plates to rods
[62]. Recent studies demonstrate that these measures
improve fracture prediction and are sensitive to structure
changes induced by testosterone replacement in hypogonadal
men [63] and hormone replacement therapy in women [64].
We recently completed a pilot study of μMRI in 17 young
adults on maintenance hemodialysis compared with healthy
controls [65]. Figure 5 illustrates the cortical thinning and
disruption of trabecular architecture in a young adult male
with severe uncontrolled renal osteodystrophy of many
years duration, ultimately resulting in parathyroidectomy.
BV/TV did not differ significantly in this small sample of
Fig. 3 Receiver operating characteristic (ROC) curves for dual-
energy X-ray absorptiometry (DXA) areal bone mineral density
(BMD) in the hip and peripheral skeleton quantitative computed
tomography (pQCT) cortical volumetric BMD (vBMD) in the
midshaft of the radius in dialysis patients (From Jamal et al. [59])
Controls Renal Osteodystrophy
Fig. 4 Axial micro computed tomography (μCT) images (8.2-μm
resolution) in the femoral neck illustrate the effects of renal osteodys-
trophy on trabecular microarchitecture in growing rats. (Adapted from






Fig. 5 Tibia micro magnetic resonance imaging (μMRI) illustrates
severe cortical thinning and loss of trabecular connectivity and bone
volume in a hemodialysis patient compared with a healthy age- and
gender-matched control (Adapted from Wehrli et al. [65])
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hemodialysis patients compared with controls; however, the
pattern of lower surface and greater curve voxels suggested
deterioration of the trabecular network.
Two cross-sectional studies used high-resolution CT [66]
or MRI [67] to evaluate trabecular architecture in renal
transplant recipients; patients were evaluated months to years
after transplantation. Grotz et al. reported that vertebral
deformities were associated with lower trabecular area, lower
trabecular diameter, and increased intertrabecular spacing in
transplant recipients compared with transplant recipients
without vertebral deformities [66]. Link et al. reported that
transplant recipients had significantly lower MRI measures
of BV/TV, Tb.Sp, Tb.Th, and Tb.N compared with controls;
[67] however, spine QCT, trabecular BMD, and DXA hip
and spine BMD did not differ between transplant recipients
and controls. The MRI and QCT measures differed between
fracture and nonfracture end-stage renal disease (ESRD)
patients; DXA measures did not.
Summary
The 2003 National Kidney Foundation Clinical Practice
Guidelines for Bone Metabolism and Disease in CKD
recommended the following for all adult patients with CKD:
[68] “Bone mineral density should be measured by dual
energy X-ray absorptiometry in patients with fractures and in
those with known risk factors for osteoporosis.” These
guidelines did not specify the measurement site. The
pediatric guidelines did not recommend DXA in children,
given the limitations in CKD and the lack of consensus on
the optimal approach to adjust for the confounding effect of
bone size during growth [69]. More recently, the Kidney
Disease: Improving Global Outcomes working group pub-
lished a position paper of the evaluation of renal osteodys-
trophy [70]. The report concluded that the value of DXA
BMD measurement in the evaluation of CKD metabolic
bone disease is not well established and concluded that the
radius is the preferred site of measurement in CKD patients,
consistent with the recommendations of the International
Society of Clinical Densitometry, as detailed above.
The assessment of the effects of renal osteodystrophy
and its potential therapies on fracture risk requires novel
imaging techniques to characterize accurately the effects on
trabecular and cortical bone. Recent data suggest that DXA
has minimal, if any, utility in predicating fractures in
advanced CKD. Valid surrogate measures of fracture risk
(e.g. QCT measures of cortical vBMD or μMRI measures
of trabecular connectivity) are required for clinical trials of
therapeutic agents. Ongoing research in this field will guide
future studies to improve bone strength and decrease
fracture rates in a population that will continue to require
renal replacement therapies throughout their lifetime.
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